Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2389

May 6, 2017

Scientists Just Transplanted Small Rat Heads Onto Bigger Rats

Posted by in categories: biotech/medical, neuroscience

Researches successfully avoided brain-damaging blood loss while the donor head was being attached to the recipient rat.

The world has been gifted, or maybe cursed, with the latest iteration of creepy head transplant experiments.

In a new study published in CNS Neuroscience and Therapeutics, researchers in China grafted the heads of smaller rats onto the necks of larger rats because we all know that rats with two heads are better than rats with one.

Continue reading “Scientists Just Transplanted Small Rat Heads Onto Bigger Rats” »

May 6, 2017

“Exercise in a Pill” Boosts Athletic Endurance

Posted by in categories: biotech/medical, health

Summary: Chemical compound mimics the beneficial effects of exercise, including fat burning and increasing stamina, a new study reports.

Source: Salk Institute.

Continue reading “‘Exercise in a Pill’ Boosts Athletic Endurance” »

May 5, 2017

Researchers identify 6,500 genes that are expressed differently in men and women

Posted by in categories: biotech/medical, evolution, genetics, sex

Men and women differ in obvious and less obvious ways—for example, in the prevalence of certain diseases or reactions to drugs. How are these connected to one’s sex? Weizmann Institute of Science researchers recently uncovered thousands of human genes that are expressed—copied out to make proteins—differently in the two sexes. Their findings showed that harmful mutations in these particular genes tend to accumulate in the population in relatively high frequencies, and the study explains why. The detailed map of these genes, reported in BMC Biology, provides evidence that males and females undergo a sort of separate, but interconnected evolution.

Several years ago, Prof. Shmuel Pietrokovski and Dr. Moran Gershoni of the Weizmann Institute’s Molecular Genetics Department asked why the prevalence of certain human diseases is common. Specifically, about 15% of couples trying to conceive are defined as infertile, which suggested that mutations that impair fertility are relatively widespread. This seems paradoxical: Common sense says that these mutations, which directly affect the survival of the species by reducing the number of offspring, should have been quickly weeded out by natural selection. Pietrokovski and Gershoni showed that mutations in genes specific to sperm formation persist precisely because the genes are expressed only in men. A mutation that is problematic for only half the population, no matter how detrimental, is freely passed on to the next generation by the other half.

In the present study, the researchers expanded their analyses to include genes that, though not necessary for fertility, are still expressed differently in the two sexes. To identify these genes, the scientists turned to the GTEx project—a very large study of human recorded for numerous organs and tissues in the bodies of close to 550 adult donors. That project enabled, for the first time, the comprehensive mapping of the human sex-differential genetic architecture.

Continue reading “Researchers identify 6,500 genes that are expressed differently in men and women” »

May 5, 2017

Bottlenecks to the Development of Rejuvenation Biotechnology

Posted by in categories: biotech/medical, genetics, life extension

What are the bottlenecks in developing a rejuvenation biotechnology industry? LEAF takes a look at some of the main problems we are facing in creating that industry.


One of the most frequent questions we get from the general public is when will rejuvenation therapies arrive? Whilst young people can wait for a few more decades, those in middle age are much more concerned. According to statistics, new drug development takes 17 years on average, but the countdown only begins at the moment when the underlying mechanisms are investigated well enough – which cannot be said about the mechanisms of aging.

We have made great progress in understanding aging in the last decade thanks to the march of technology. One solution to an aging process is entering human clinical trials this year: a therapy to remove aged damaged cells to promote tissue repair and reduce chronic inflammation. This is of course fantastic news but progress is still too slow.

Continue reading “Bottlenecks to the Development of Rejuvenation Biotechnology” »

May 4, 2017

This Frog Oozes Mucus That Causes Flu Virus Particles to Explode

Posted by in category: biotech/medical

  • Researchers have discovered that a compound in the mucus found on the back of a frog can cause flu virus particles to explode.
  • If they can harness this compound, called urumin, they may be able to create a universal flu vaccine.

A compound in the mucus found on the oozy backs of a South Indian frog — known locally as a germ killer — can cause flu virus particles to explode. Researchers at Emory University have discovered that the compound, a peptide they’ve called urumin, is potent, yet precise, and capable of destroying an entire class of flu viruses while other cells and even other viruses emerge unscathed. Unlike other frog-based compounds, urumin is uniquely nontoxic, another unusual feature that makes it more promising from a therapeutic standpoint.

Read more

May 3, 2017

Robots Could Soon Have More Sensitive Skin Than You Do

Posted by in categories: biotech/medical, cyborgs, robotics/AI

Robots may soon be more sensitive than humans—at least when it comes to their skin. Researchers from Glasgow University have developed a type of artificial skin that is more sensitive than our own. Just add this to all the ways robots are taking over the world.

Related: A Robot Performed Soft-Tissue Surgery By Itself

Read more

May 3, 2017

Tensions Flare as Scientists Go Public With Plan to Build Synthetic Human DNA

Posted by in categories: bioengineering, biotech/medical, genetics

One of the greatest ethical debates in science — manipulating the fundamental building blocks of life — is set to heat up once more.

According to scientists behind an ambitious and controversial plan to write the human genome from the ground up, synthesising DNA and incorporating it into mammalian and even human cells could be as little as four to five years away.

Nearly 200 leading researchers in genetics and bioengineering are expected to attend a meeting in New York City next week, to discuss the next stages of what is now called the Genome Project-write (GP-write) plan: a US$100 million venture to research, engineer, and test living systems of model organisms, including the human genome.

Continue reading “Tensions Flare as Scientists Go Public With Plan to Build Synthetic Human DNA” »

May 3, 2017

Treating Osteoarthritis

Posted by in categories: biotech/medical, life extension

New research in multiple mouse types and human cell lines shows senolytics helps mitigate osteoarthritis.


The removal of senescent cells has shown further potential for the treatment of osteoarthritis in this recent publication where the researchers reduce the impact of post injury osteoarthritis by clearing senescent cells[1]. As we have discussed many times in our publications, senescent cells are a key player in the aging process, if you are new to the subject and want to know what senescent cells are here is a quick primer.

What are senescent cells?

Continue reading “Treating Osteoarthritis” »

May 3, 2017

Zoltan Istvan

Posted by in categories: biotech/medical, transhumanism

I’m giving a speech this morning in San Diego on #transhumanism. If you’re at this medical device conference, please come listen and say hello after the talk:


The 10x Medical Device Conference is an annual, in-person reuinion for the Medical Devices Group, the world’s largest medical device community.

Read more

May 3, 2017

“Exercise-in-a-pill” boosts athletic endurance

Posted by in categories: biotech/medical, health

The push to find exercise memetics continues.


Every week, there seems to be another story about the health benefits of running. That’s great—but what if you can’t run? For the elderly, obese or otherwise mobility-limited, the rewards of aerobic exercise have long been out of reach.

Continue reading “‘Exercise-in-a-pill’ boosts athletic endurance” »